Background: Cardiometabolic affections greatly contribute to the global burden of disease. The
Background
Obesity, cardiovascular disease and type 2 diabetes are notable contributors to the global burden of disease [1] . Seminal studies in monozygotic twins demonstrated that these cardiometabolic diseases are heritable [2] [3] [4] , but genome-wide association studies (GWAS) have failed to consistently uncover replicable variants across human populations, with notable exceptions [5, 6] . One possible explanation for this is that the identification of variants in candidate genes is highly dependent on the ethnic and geographic origin of the studied population [7] . Differences in allele frequencies and linkage disequilibrium structure make difficult the extrapolation of results between human groups with different genetic backgrounds. Therefore, the ancestral genetic composition of the studied population becomes a key element in association studies [8] .
Additionally, the lack of replicability of many GWAS results across populations may be explained by the interactions between gene variants and non-genetic factors affecting the aforementioned complex phenotypes [9] . The gut microbiota, the set of microorganisms that naturally colonize the human intestine [10] , is one of such factors. The gut microbiota has been shown to be central to host health [11] [12] [13] , and to be shaped by human genetics [14, 15] . Despite the impact of recent discoveries on the relationship between gut microbes and human health, the degree to which associations found in one population can extend to another is still unclear. The geographic origin of human populations is one of the most important factors shaping the composition of this microbial community [16, 17] , yet it is unknown whether such biogeographic pattern is explained by host genetics or by non-genetic factors correlated with geography and ancestry (e.g., diet, lifestyle). Studies explicitly testing associations between host genetic ancestry and gut microbiota are still very rare [18] .
In this study, we analyzed a cohort of Colombian adults, whose genetic background is product of extensive recent admixture between three continental populations: Europeans, Native Americans and Africans [19] . In these individuals, we estimated the ancestral genetic composition with ancestry informative markers (AIMs), characterized gut microbiota through high-throughput 16S rRNA gene sequencing and measured numerous variables that inform about diet, lifestyle and cardiometabolic disease risk. We aimed to determine whether the ancestral genetic composition of this population was associated with the structure of the gut microbiota, and split apart the effects of genetic and non-genetic factors on human health.
Results

The city of origin accounts for differences in the ancestral genetic composition
We performed a cross-sectional study in which we enrolled 441 adult Colombian mestizos in roughly similar proportions across five cities spanning the Colombian Andes and both its Caribbean and Pacific coasts (Bogota, Medellin, Cali, Barranquilla and Bucaramanga); body mass index (BMI: lean, overweight, obese); sex (male, female); and age range (18-40 years, 41-62 years). We characterized the ancestral genetic composition in 440 of these participants using a panel of 40 ancestry informative markers (AIMs) that have been previously shown to discriminate among European, Native American and African populations [20, 21] (Table S1 ). One individual of our cohort could not be genotyped because we were not able to acquire DNA from blood. Overall, the 40 evaluated AIMs were found in Hardy-Weinberg equilibrium (all p>0.05 in exact Hardy-Weinberg tests). Figure 1B-1D ). In agreement with this, we found evidence of limited but significant genetic structure (mean F st ± SE = 0.004 ± 0.001, 95% CI = 0.002-0.006). However, there was no evidence of isolation by distance, according to a Mantel test considering genetic (F st /(1-F st )) and log-transformed geographic distance matrices (r = -0.43, 95% CI = -0.94-0.14, two-tailed p = 0.43). Furthermore, we did not find significant differences in the ancestral genetic composition by other factors controlled by design (p>0.10 in all ANOVAs for BMI, sex and age range).
Next, we performed a robust principal component analysis (PCA) for compositional data based on the individual proportions of European, Native American and African, and found a gradient where the first component (PC1) distinguished Native American and African ancestries, whereas the second component (PC2) discerned European and non-European ancestries ( Figure   2A -2C). In accordance with our previous result, these two components differed among the cities from which participants originated (ANOVA for PC1: F 4,435 = 7.60, p<0.0001; PC2: F 4,435 = 3.63, p = 0.006) but did not differ by BMI, sex or age range (p>0.10 in all ANOVAs).
Limited evidence of an association between host genetic ancestry and gut microbiota
Afterwards, we sought to examine whether the host genetic ancestry associated with the composition of gut microbiota. We analyzed the complete microbial community through principal coordinate analysis (PCoA) using weighted UniFrac distances on rarefied sequence counts, and found that the gut microbiota of Colombians formed a single point cloud of microbial abundances. Beta-diversity analyses indicated that differences in the structure of the microbial We further examined whether specific groups of microbes were associated with the host genetic ancestry. Figure S1 ). However, they did not relate to the host genetic ancestry after accounting for covariates (p>0.10 for genetic PC1 and PC2 for both taxa).
Cardiometabolic health outcomes are better explained by gut microbiota composition than by host genetic ancestry
Considering that we found limited evidence of an association between gut microbiota and host genetic ancestry, we next examined whether gut microbes and the participants' ancestral genetic composition each associated with variables related to cardiometabolic health, diet and lifestyle. The risk of disease was assessed through a summary measure-the cardiometabolic risk scale-which totaled Z-scores of waist circumference, triglycerides, fasting insulin, diastolic blood pressure and high-sensitive C reactive protein (hs-CRP). These variables informed about different conditions involved in cardiometabolic disease, namely central obesity, dyslipidemia, insulin resistance, hypertension and low-grade systemic inflammation, respectively.
Individuals with high values of the cardiometabolic risk scale were more likely to be male; to be of older age; to have low levels of high density lipoprotein (HDL) cholesterol; high levels of total cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol, and triglycerides; high levels of fasting glucose, glycated hemoglobin (HbA1c), fasting insulin and insulin resistance (HOMA-IR); high levels of hs-CRP, blood pressure and adiposity (BMI, waist circumference and body fat); and to regularly smoke and consume medications. In addition, these individuals were more likely to suffer of coronary heart disease, as assessed by the Framingham score [22] . While the cardiometabolic disease risk was not associated with genetic ancestry, diet intake or levels of physical activity, it was significantly associated with gut microbiota composition ( Table 1) .
We verified these results by correlating variables summarizing genetic ancestry (PCA components) and gut microbiota (first two PCoA axes of weighted UniFrac) with biochemical profiles, blood pressure, adiposity, diet and physical activity. For this, we fitted linear models adjusted for the city of origin, sex, age, smoking status and medicament consumption, and calculated Spearman correlation coefficients between pairs of adjusted variables, so that correlations were independent of the aforementioned covariates. We found that the levels of blood insulin were negatively correlated with genetic PC2 (i.e., individuals with higher nonEuropean ancestries had higher insulin levels). On the other hand, microbiota PCoA axes were significantly associated with glucose metabolism (fasting glucose levels), hypertension (blood pressure), obesity (BMI and % body fat), central obesity (waist circumference), and fiber intake ( Table 2) .
We next examined the contributions of host genetic ancestry, gut microbiota and their interaction to explain variance in cardiometabolic disease risk using multivariable-adjusted linear models. Models were adjusted for the city of origin, sex, age, calorie and fiber intakes, levels of physical activity, smoking status and medicament consumption. Based on likelihood-ratio tests and the Akaike information criterion (AIC), we found that gut microbiota composition explained more variance in the risk of cardiometabolic disease than genetic ancestry (model including genetic ancestry: (Table S4) . The model that best explained variance in insulin levels was that considering genetic ancestry, whereas triglycerides levels were best explained by the ancestry × gut microbiota interaction. Neither genetic ancestry nor gut microbiota seemed to significantly contribute to explain variance in hs-CRP levels ( Table   S4 ).
Considering that gut microbiota associated with more health-related variables than genetic ancestry, we identified particular OTUs associated with cardiometabolic outcomes. 
Discussion
Gut microbiota composition and the host genetic background have been each associated with human cardiometabolic health. However, the evidence associating the microbial community and the host genetic ancestry is sparse. We examined associations among host ancestry, gut microbiota and cardiometabolic health in a population with a history of recent, extensive admixture between Europeans, Native Americans and Africans [19] . Importantly, we quantified the levels of genetic admixture using ancestry informative markers (AIMs) located on most chromosomes, in opposition to self-reported ancestry [18, 23] . While we found strong connections between gut microbiota and cardiometabolic health, the evidence associating these variables with the host genetic ancestry was limited.
The studied population had an admixed genetic composition typical of urban Latin
American mestizos, with predominance of European, followed by Native American and African ancestries [19] . Overall, the contributions of each ancestral component followed a previously described geographic pattern, where inhabitants of the inner, Andean regions (Bogota, Medellin and Bucaramanga) had the highest European ancestry; those North and Northwest the lowest Amerindian ancestry (Medellin and Barranquilla); and those on the Caribbean and Pacific coasts (Barranquilla and Cali) the highest African ancestry [19, 24] . These results confirmed that the city of origin was associated with the ancestral genetic composition of the studied population and that the panel of selected AIMs adequately replicated results from previous studies in Colombians.
Comparative cross-species studies indicate that hosts and symbionts have coevolved for millions of years [25, 26] , suggesting a heritable basis in this interaction. In agreement with this, recent studies in mice and humans suggest that gut microbiota is partly under the host genetic control [27] [28] [29] [30] , and particular microbes have been shown to be heritable [31] . However, the contribution of the host genetic ancestry to gut microbiota composition has been poorly studied, albeit it could be crucial to explain pervasive inter-population differences in this community [16, 17] .
We found a general lack of association between host genetic ancestry and gut microbiota composition in a mestizo population, agreeing with a recent study performed in Israel considering a variety of self-reported ancestries, including Ashkenazi, North African, Middle Eastern, Sephardi, Yemenite and admixed [18] . The only correlations detected in our study between genetic ancestry and gut microbiota came from Enterococcaceae and Otu00068 (E.
casseliflavus), whose association with African ancestry was confounded by non-genetic factors, specifically the city of origin and cigarette consumption.
Multiethnic surveys have demonstrated that the origin of human populations contribute to the genetic predisposition to disease. Here, we found that individuals with higher Amerindian and African ancestries had higher blood insulin, independent of potential non-genetic confounders, including sex, age, the city of origin, diet and lifestyle. Studies in Mexican-Americans [32] , US Native Americans [33] and Alaska Natives [34] have shown higher risk of type 2 diabetes in individuals of Amerindian ancestry. Likewise, Africans, African Americans and geneticallyadmixed individuals with high African ancestry have higher risk of this disease [35] [36] [37] [38] .
Our analyses, however, did not reveal further associations between the ancestral genetic composition and cardiometabolic health. This contrasts with recent studies performed in Colombians, which have shown associations between Native American ancestry and high triglyceride levels [39] ; African ancestry, high blood pressure and high risk of type 2 diabetes [38, 39] ; European ancestry and low risk of type 2 diabetes [40] . One possible explanation for the general lack of association between genetic ancestry and health of our study could be the relative homogeneity in the individual proportions of European, Native American and African ( Figure   1A ). Unlike studies in which subjects with very dissimilar origin are compared, the individuals analyzed here were all mestizos with roughly similar admixed ancestry. The inclusion of individuals with more diverse genetic backgrounds could allow finding clearer health-ancestry associations [38, 41, 42 ].
An alternative, non-exclusive explanation could be that the correlations between genetic ancestry and health are actually small and require larger sample sizes and more AIMs to uncover them. For the former, we calculated the sample sizes needed to detect statistically significant differences in genetic ancestry among tertiles of the cardiometabolic risk scale, as reported in Table 1 , and found that the statistical power of our study was indeed limited. For [19] . In addition, our ancestry estimates at the population level were similar to those obtained in studies evaluating different set of variants [19] and population samples [39] .
While the evidence associating genetic ancestry and health in our cohort was weak, the association between gut microbes and cardiometabolic outcomes was stronger. We found that the microbiota composition was a better explanatory variable of the risk of cardiometabolic disease than genetic ancestry, and informed about central obesity, hypertension and coronary heart disease. Further, we uncovered a list of particular OTUs associated with disease risk in the studied population. This included microbes that have been shown to be more abundant in patients with atherosclerotic disease, such as E. coli and Atopobium [11] ; in type 2 diabetic patients, such
as Clostridiaceae SMB53 [43] ; and in unhealthy obese individuals, such as E. coli, Gemmiger formicilis and Clostridiaceae SMB53 [44] . On the other hand, microbes such as A. muciniphila, Oscillospira, Methanobrevibacter and Christensenellaceae have been shown to be associated to healthy cardiometabolic states [14, [45] [46] [47] .
Our study had several strengths, including a thorough sampling in several cities and an indepth characterization of the studied cohort in terms of genetic ancestry, gut microbiota, cardiometabolic health outcomes and non-genetic factors associated with diet and lifestyle that allowed adjusting statistical models for potential confounding. However, for some comparisons we were limited by the sample size of our study, by the number of evaluated AIMs and by the fact that this was a cross-sectional study, so that we cannot distinguish cause and effect.
Conclusions
Genetic-association studies have given great insights into the nature of complex phenotypes, such as cardiometabolic diseases. Accumulating evidence on non-genetic factors intimately linked to the host, such as the gut microbiota, has enriched this picture, demonstrating an intimate and complex connection between symbionts and human health. We here showed that the specific composition of gut microbes has a dramatic effect on disease risk, ultimately opening a promising avenue to ameliorate human health through targeted modulation of the microbial community. Our results, and those recently obtained in a different population [18] , suggest that modulation strategies could be applied regardless of the genetic ancestry of the intervened population.
Methods
Study population
We enrolled 441 mestizo adult men and women, living in the cities of Bogota, Medellin, 
Genotyping of ancestry informative markers (AIMs)
The ancestral genetic composition of participants was assessed through a panel of 40
AIMs located on most chromosomes, chosen for having strong differences in allele frequency between European, Native American and African populations, and to be unlinked (Table S1 ). The selected AIMs have been previously used [24, 39, 48, 49] . Of these, 34 corresponded to insertion/deletion variants (INDELs) and six to single nucleotide polymorphisms (SNPs). Primers and PCR conditions followed specific protocols for each AIM. For INDELs, genotypes were resolved with 1.5-2.0% agarose gel electrophoresis if the variant was >10 bp, otherwise with capillary electrophoresis in an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). SNPs were genotyped with PCR-RFLP and resolved with 2.5-3.0% agarose gel electrophoresis.
Analysis of host genetic ancestry
The host genetic ancestry was analyzed as follows: genotypes for each AIM served to calculate the observed and expected allelic and genotypic frequencies, to test the HardyWeinberg equilibrium with an exact test [50] , and to estimate overall population structure (F st ) using the Weir and Cockerham estimator [51] . The standard error and 95% confidence intervals of this estimator were calculated by jackknifing and bootstrapping over loci, respectively.
Population-genetic analyses were performed with GenePop [52] and FSTAT 2.9.3 [53] .
Afterwards, we tested isolation by distance by correlating genetic (F st /(1-F st )) and (logtransformed) geographic distance matrices using a Mantel test, as implemented in the ecodist package of R [54] , with 10,000 permutations and 10,000 bootstrap iterations for calculating confidence intervals.
Next, a hidden Markov model approach was used to infer the individual genetic contributions of European, Native American and African ancestries using ADMIXMAP 3.7. [55] .
This method models individual admixture using genotypic information for all individuals and AIMs, the AIM's physical position in the chromosome and the frequency of the largest allele in parental populations. Allelic frequencies in the parental populations were previously reported for Europeans (Spain, Germany, England, Ireland), Native Americans (Maya, Pima and Puebla) and Africans (Nigeria, Sierra Leone, Central African Republic, African-American and AfroCaribbean) [56, 57] . The parameters used for running ADMIXMAP were: 40 loci, 440 diploid individuals, 250,000 iterations with a burn-in of 10,000 iterations, and a model of three populations.
The proportions of European, Native American and African ancestries were compared across the five cities from which our participants originated, BMI (lean, overweight, obese), sex (male, female) and age range (18-40, 41-62 years) with ANOVA, after verifying homoscedasticity with the Fligner-Killeen test. Where necessary, data were transformed with natural logarithm for unbounded variables, or arcsin square root for proportions. We also performed robust principal components analysis (PCA) for compositional data with the individual proportions of the three genetic ancestries using the robCompositions package of R [58] . For this, the compositional dataset was transformed using the isometric log ratio, and a PCA was afterwards performed. PC1 and PC2 components were compared across cities, BMI, sex and age range using ANOVA.
Gut-microbiota characterization
Detailed laboratory and bioinformatic procedures can be found elsewhere [59] . Briefly, each participant collected a fecal sample from which the total microbial DNA was extracted using the QIAamp DNA Stool Mini Kit (Qiagen; Hilden, Germany). The V4 region of the 16S
rRNA gene was amplified with primers F515 and R806, sequenced with Illumina MiSeq v2, and processed as previously described [59] .
The gut microbiota was analyzed at the whole community level using principal coordinate analysis (PCoA) based on weighted UniFrac distances. These distances were computed on rarefied sequence counts (3667 reads/sample) with the GUniFrac package of R [60] , and compared across cities, BMI, sex and age range with permutational multivariate analysis of variance using distance matrices (PERMANOVA), as implemented in the Vegan package of R [61] . Microbiota analyses were also performed at the phylum, class, order, family, genus and species level, as well as at the OTU level. For taxonomy-based tests, we calculated the relative abundance of microbial sequences classified at all taxonomic ranks according to the Greengenes 13_8_99 taxonomy [62] . At the OTU level, we grouped sequences at 97% identity using the average neighbor algorithm [63] , and extracted the OTUs that had median relative abundances ≥ 0.01% across all samples. The latter procedure guaranteed that the majority of sequences was analyzed (~80% of total reads) and minimized the impact of sequencing artifacts.
Cardiometabolic health, diet and lifestyle
We measured several variables that might interact with both gut microbiota and the host genetic ancestry. These included health-related variables (blood chemistry, blood pressure and adiposity), diet intake (calories, macronutrients and dietary fiber) and lifestyle (physical activity, smoking status, medicament consumption). Detailed information about measurement of these variables is presented elsewhere [44] . Briefly, blood biochemical variables, including HDL, LDL, VLDL, total cholesterol, triglycerides, fasting glucose, HbA1c, fasting insulin, and hs-CRP, were measured using standard techniques routinely used in a clinical laboratory (Dinámica IPS, Medellin, Colombia). Blood insulin served to calculate the insulin resistance index using the homeostasis model assessment (HOMA-IR). The systolic and diastolic blood pressures were measured in mm Hg with a Rossmax AF701f digital tensiometer (Berneck, Switzerland).
Adiposity was assessed through BMI (weight (kg)/height squared (m 2 )), waist circumference (cm) and percentage body fat (calculated with the thicknesses of four skinfolds: biceps, triceps, subscapular and ileocrestal).
To assess the risk of cardiometabolic disease, we constructed a summary scale-the cardiometabolic risk scale-by summing Z-scores of waist circumference, triglycerides, fasting insulin, diastolic blood pressure and hs-CRP (Z = [x-µ]/δ, where µ is the population mean and δ is the standard deviation of the population). Variables were log-transformed to adjust to a normal distribution before obtaining Z-scores. These variables were chosen because they informed about different conditions involved in cardiometabolic disease: central obesity, dyslipidemia, insulin resistance, hypertension and low-grade systemic inflammation, respectively. In addition, we calculated the Framingham coronary heart disease score [22] using sex, age, diabetes status, smoking status, blood pressure, HDL and total cholesterol as predictor variables. Since the Framingham score did not consider individuals younger than 30 years, these were given the lowest age score (-1).
Daily intakes of macronutrients (g/day of carbohydrates, protein and fat), dietary fiber (g/day) and calories (kcal/day) were estimated with 24-hour dietary recall interviews [64] .
Physical activity (number of metabolic equivalents per minute per week: MET/min/week) with the short form of the International Physical Activity Questionnaire [65] . Smoking and medicament consumption were self-reported in specific questionnaires. For the latter, we considered all drugs taken by participants on a regular basis during the three months prior to enrollment, to the exception of over-the-counter vitamin and mineral supplements, phytotherapeutics and contraceptives. All measurements and questionnaires were performed by trained personnel.
Associations of host genetic ancestry, gut microbiota and cardiometabolic health
The direct association between host genetic ancestry and microbiota composition was assessed with Procrustes analyses. These were performed to examine, on one hand, the correlation between the weighted UniFrac distance matrix and the matrix of individual proportions of European, Native American and African; and, on the other hand, the correlation between the first two PCoA axes of the microbiota analysis and the PCA components of genetic ancestry. In both cases, microbiota matrices were set as targets and genetic ancestry matrices as those to be rotated and scaled. Statistical significance was determined using 10,000 permutations.
We also explored associations between genetic ancestry and microbiota composition at the phylum, class, order, family, genus, species and OTU levels. In these cases, we correlated the relative abundance of each microbial group with the individual proportions of European, Native
American and African, as well as with the two genetic PCA components, using Spearman correlation tests; p-values were adjusted for multiple comparisons (FDR) using the BenjaminiHochberg method.
To dissect the effects of genetic ancestry and non-genetic factors on the abundance of particular groups of microbes, we fitted linear regression models in which the relative abundance of each microbial group was modeled in function of genetic ancestry (PCA components), city of origin, sex, age, diet (calorie and fiber intakes) and lifestyle (physical activity levels, smoking status, and medicament consumption). In these cases, relative abundances were arcsin square-root transformed.
We next investigated associations of the host genetic ancestry and gut microbiota composition with cardiometabolic health. For this, we divided the cardiometabolic risk scale by tertiles (low, middle and high risk) and tested differences among them for each variable using ANOVA and chi-square tests. Where necessary, variables were appropriately transformed as mentioned above.
Afterwards, we correlated variables informing about genetic ancestry (PCA components) and gut microbiota (first two PCoA axes of weighted UniFrac) with cardiometabolic outcomes, diet and physical activity. For this, we fitted linear models adjusted for the city of origin, sex, age, smoking status and medicament consumption, calculated Spearman correlation coefficients and obtained FDR-adjusted p-values for all pairs of adjusted variables.
To examine the contributions of host genetic ancestry, gut microbiota and their interaction in explaining cardiometabolic disease risk, we fitted several linear models. The basic model included the city of origin, sex, age, calorie and fiber intakes, levels of physical activity, smoking status and medicament consumption. We then evaluated alternative models including genetic ancestry (PCA components), gut microbiota (first two PCoA axes of weighted UniFrac) and the genetic ancestry × gut microbiota interaction. The first two alternative models were each compared against the basic model, the latter model was compared against the best preceding model. We obtained log-likelihoods of all models and evaluated their changes with likelihood ratio tests. Model selection was based on AIC. Models were fitted for the cardiometabolic risk scale, for individual variables adding up to this scale and for the Framingham coronary heart disease score.
Finally, we identified particular OTUs associated with cardiometabolic outcomes by fitting quasi-Poisson GLMs on rarefied sequence counts, adjusting for the city of origin, sex, age, calorie and fiber intakes, physical activity, smoking status and medicament consumption. The residuals of these GLMs were then correlated with cardiometabolic outcomes using Spearman correlation coefficients and FDR-adjusted p-values.
Power calculation
We performed statistical power calculations to determine the sample sizes required to observe significant differences in genetic ancestry among tertiles of cardiometabolic disease risk, using the pwr package of R [66] . For this, we set the significance level (α = 0.05) and statistical power (β = 0.80), calculated the within-group variance for each ancestral genetic composition (proportions of European, Native American and African), and effect sizes (f). The latter were calculated using:
where k is the number of groups, p i = n i /N, n i is the number of observations in group i, N is the total number of observations, µ i is the mean in group i, µ is the grand mean, and σ 2 is the error variance within groups [67] . 
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